FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Haiyong Han

Research Profile

Disorders

Pancreatic Neoplasms

Anatomy

Tumor Cell Line

Chemicals & Drugs

Concepts & Ideas

Nucleic Acid Conformation

Procedures

Physiology

Co-author Network

Publications

TOP 3
Robert T Dorr; Haiyong Han; Suzu Igarashi; Terry Landowski; Betty K Samulitis; Paul Beroza; Komath Damodaran; Lee Wisner; Yu Zhao; Daniel D Von Hoff
Characterization of a membrane-active anti-tumor agent, UA8967.
Haiyong Han; Daniel D Von Hoff
SnapShot: pancreatic cancer.
Ruben M Munoz; Konstantinos Petritis; Tony Tegeler; Daniel D Von Hoff; Haiyong Han; Stanley A Hoffman
Isolation and characterization of muscle fatigue substance with anti-tumor activities.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Haiyong Han (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Robert T Dorr; Haiyong Han; Suzu Igarashi; Terry Landowski; Betty K Samulitis; Paul Beroza; Komath Damodaran; Lee Wisner; Yu Zhao; Daniel D Von Hoff
Characterization of a membrane-active anti-tumor agent, UA8967.
Investigational new drugs 2013;31(3):576-86.
2013: Haiyong Han; Daniel D Von Hoff
SnapShot: pancreatic cancer.
Cancer cell 2013;23(3):424-424.e1.
2013: Ruben M Munoz; Konstantinos Petritis; Tony Tegeler; Daniel D Von Hoff; Haiyong Han; Stanley A Hoffman
Isolation and characterization of muscle fatigue substance with anti-tumor activities.
Journal of Cancer 2013;4(4):343-9.
2013: Clifford Whatcott; Haiyong Han; Richard G Posner; Daniel D Von Hoff
Tumor-stromal interactions in pancreatic cancer.
Critical reviews in oncogenesis 2013;18(1-2):135-51.
2012: Lifang Xie; Hongwei H Yin; Yu Zhao; Michelle Kassner; Jeff Kiefer; Spyro Mousses; Ruben M Munoz; Qiang Q Que; Daniel D Von Hoff; Haiyong Han
Kinome-wide siRNA screening identifies molecular targets mediating the sensitivity of pancreatic cancer cells to Aurora kinase inhibitors.
Biochemical pharmacology 2012;83(4):452-61.
2012: Winnie S Liang; Lori Phillips; Richard Posner; Ramesh K Ramanathan; Shripad Sinari; A Keith Stewart; Edward C Stites; Waibhav Tembe; Glen J Weiss; Jessica Aldrich; Angela Baker; Michael Barrett; Hollie Benson; Mitesh J Borad; Esteban Braggio; John D Carpten; Alexis Christoforides; David Craig; Micheal J Demeure; Jan B Egan; Rafael Fonseca; Haiyong Han; Galen H Hostetter; Tyler Izatt; Jeffrey A Kiefer; Ahmet Kurdoglu; Douglas Lake; Christophe Legendre; Daniel Von Hoff
Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencing.
PloS one 2012;7(10):e43192.
2012: Matthew S Creamer; Haiyong Han; William S Hlavacek; Meraj Aziz; Michael E Berens; Kimberley J Bussey; James A Cahill; Edward C Stites; Chin Wee Tan; Daniel D Von Hoff; Richard G Posner
Specification, annotation, visualization and simulation of a large rule-based model for ERBB receptor signaling.
BMC systems biology 2012;6():107.
2012: Bret Stephens; Stephen P Anthony; Michael Barrett; Haiyong Han; Galen Hostetter; Jeffery Kiefer; Daniel D Von Hoff
Molecular Characterization of a Patient's Small Cell Carcinoma of the Ovary of the Hypercalcemic Type.
Journal of Cancer 2012;3():58-66.
2011: Aditi A Bapat; Galen Hostetter; Daniel Von Hoff; Haiyong Han
Perineural invasion and associated pain in pancreatic cancer.
Nature reviews. Cancer 2011;11(10):695-707.
2011: Clifford J Whatcott; Haiyong Han; Galen Hostetter; Richard G Posner; Daniel D Von Hoff
Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look.
Cancer discovery 2011;1(4):291-6.
2011: Caroline H Diep; Ruben M Munoz; Ashish Choudhary; Daniel Von Hoff; Haiyong Han
Synergistic effect between erlotinib and MEK inhibitors in KRAS wild-type human pancreatic cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(9):2744-56.
2010: David L Morse; yoganand balagurunathan; Galen Hostetter; Maria Trissal; Narges K Tafreshi; Nancy Burke; Mark Lloyd; Steven Enkemann; Domenico Coppola; Victor J Hruby; Robert J Gillies; Haiyong Han
Identification of novel pancreatic adenocarcinoma cell-surface targets by gene expression profiling and tissue microarray.
Biochemical pharmacology 2010;80(5):748-54.
2010: Haiyong Han; Yu Zhao; Timothy Cuthbertson; Rosemarie F Hartman; Seth D. Rose
Cell cycle arrest and apoptosis induction by an anticancer chalcone epoxide.
Archiv der Pharmazie 2010;343(8):429-39.
2010: David L Morse; Galen Hostetter; yoganand balagurunathan; Robert J Gillies; Haiyong Han
Identification of pancreatic cancer-specific cell-surface markers for development of targeting ligands.
Methods in molecular biology (Clifton, N.J.) 2010;624():195-210.
2009: Steven L Warner; Bret J Stephens; Stanley Nwokenkwo; Galen Hostetter; Anastasia Sugeng; Manuel Hidalgo; Jeffrey M. Trent; Haiyong Han; Daniel Von Hoff
Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(21):6519-28.
2009: Arthur Y Shaw; Meredith C Henderson; Gary Flynn; Betty Samulitis; Haiyong Han; Steve P Stratton; H-H Sherry Chow; Laurence H Hurley; Robert T Dorr
Characterization of novel diaryl oxazole-based compounds as potential agents to treat pancreatic cancer.
The Journal of pharmacology and experimental therapeutics 2009;331(2):636-47.
2009: Liping Xu; Josef Vagner; Jatinder Josan; Ronald M Lynch; David L Morse; Brenda Baggett; Haiyong Han; Eugene A. Mash Jr.; Victor J Hruby; Robert J Gillies
Enhanced targeting with heterobivalent ligands.
Molecular cancer therapeutics 2009;8(8):2356-65.
2009: Hong Wang; Bret Stephens; Daniel Von Hoff; Haiyong Han
Identification and characterization of a novel anticancer agent with selectivity against deleted in pancreatic cancer locus 4 (DPC4)-deficient pancreatic and colon cancer cells.
Pancreas 2009;38(5):551-7.
2009: Meredith Henderson; Yeng-Jeng Y Shaw; Hong Wang; Haiyong Han; Laurence H Hurley; Gary Flynn; Robert T Dorr; Daniel Von Hoff
UA62784, a novel inhibitor of centromere protein E kinesin-like protein.
Molecular cancer therapeutics 2009;8(1):36-44.
2008: W N Yap; P N Chang; Haiyong Han; D T W Lee; M T Ling; Y C Wong; Y L Yap
Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways.
British journal of cancer 2008;99(11):1832-41.
2008: Shuaili Chen; Theresa Auletta; Ostap Dovirak; Christina Hutter; Karen Kuntz; Samira El-ftesi; Jude Kendall; Haiyong Han; Daniel Von Hoff; Raheela Ashfaq; Anirban Maitra; Christine A Iacobuzio-Donahue; Ralph Hruban; Robert Lucito
Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification.
Cancer biology & therapy 2008;7(11):1793-802.
2008: Steven L Warner; Ruben M Muñoz; David J Bearss; Paul Grippo; Haiyong Han; Daniel Von Hoff
Pdx-1-driven overexpression of aurora a kinase induces mild ductal dysplasia of pancreatic ducts near islets in transgenic mice.
Pancreas 2008;37(3):e39-44.
2008: yoganand balagurunathan; David L Morse; Galen Hostetter; Vijayalakshmi Shanmugam; Phillip Stafford; Sonsoles Shack; John Pearson; Maria Trissal; Micheal J Demeure; Daniel Von Hoff; Victor J Hruby; Robert J Gillies; Haiyong Han
Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer.
Molecular cancer therapeutics 2008;7(9):3071-80.
2008: Amanda F Baker; Mei Y Koh; Ryan R Williams; Brian James; Huamin Wang; Wendy R Tate; Alfred Gallegos; Daniel Von Hoff; Haiyong Han; Garth Powis
Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Pancreas 2008;36(2):178-86.
2008: Bret Stephens; Haiyong Han; Galen Hostetter; Micheal J Demeure; Daniel Von Hoff
Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cells.
Molecular cancer therapeutics 2008;7(1):202-10.
2007: Ming Zhu; Vijay Gokhale; Lajos Szabo; Ruben M Munoz; Hyounggee Baek; Sridevi Bashyam; Laurence H Hurley; Daniel Von Hoff; Haiyong Han
Identification of a novel inhibitor of urokinase-type plasminogen activator.
Molecular cancer therapeutics 2007;6(4):1348-56.
2006: Steven L Warner; Ruben M Munoz; Phillip Stafford; Erich Koller; Laurence H Hurley; Daniel Von Hoff; Haiyong Han
Comparing Aurora A and Aurora B as molecular targets for growth inhibition of pancreatic cancer cells.
Molecular cancer therapeutics 2006;5(10):2450-8.
2006: Hong Wang; Haiyong Han; Daniel Von Hoff
Identification of an agent selectively targeting DPC4 (deleted in pancreatic cancer locus 4)-deficient pancreatic cancer cells.
Cancer research 2006;66(19):9722-30.
2006: Haiyong Han; Daniel Von Hoff
Aurora sheds light on head and neck squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(17):5003-4.
2006: Hong Wang; Haiyong Han; Spyro Mousses; Daniel Von Hoff
Targeting loss-of-function mutations in tumor-suppressor genes as a strategy for development of cancer therapeutic agents.
Seminars in oncology 2006;33(4):513-20.
2006: Steven L Warner; Sridevi Bashyam; Hariprasad Vankayalapati; David J Bearss; Haiyong Han; Daruka Mahadevan; Daniel Von Hoff; Laurence H Hurley
Identification of a lead small-molecule inhibitor of the Aurora kinases using a structure-assisted, fragment-based approach.
Molecular cancer therapeutics 2006;5(7):1764-73.
2005: Bret J Stephens; Haiyong Han; Vijay Gokhale; Daniel Von Hoff
PRL phosphatases as potential molecular targets in cancer.
Molecular cancer therapeutics 2005;4(11):1653-61.
2004: Heather L Handl; Josef Vagner; Haiyong Han; Eugene A. Mash Jr.; Victor J Hruby; Robert J Gillies
Hitting multiple targets with multimeric ligands.
Expert opinion on therapeutic targets 2004;8(6):565-86.
2004: Robert Calaluce; David J Bearss; Jean Barrera; Yu Zhao; Haiyong Han; Shaleen K Beck; Kathy McDaniel; Raymond B Nagle
Laminin-5 beta3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicity.
Neoplasia (New York, N.Y.) 2004;6(5):468-79.
2004: Phillip J Gray; David J Bearss; Haiyong Han; Raymond B Nagle; Ming Tsao; Nicholas Dean; Daniel Von Hoff
Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer.
Molecular cancer therapeutics 2004;3(5):641-6.
2004: Sangeeta Rojanala; Haiyong Han; Rubén M Muñoz; Walden Browne; Raymond B Nagle; Daniel Von Hoff; David J Bearss
The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer.
Molecular cancer therapeutics 2004;3(4):451-7.
2003: Steven L Warner; David J Bearss; Haiyong Han; Daniel Von Hoff
Targeting Aurora-2 kinase in cancer.
Molecular cancer therapeutics 2003;2(6):589-95.
2002: Cory L Grand; Haiyong Han; Rubén M Muñoz; Steven D Weitman; Daniel Von Hoff; Laurence H Hurley; David J Bearss
The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo.
Molecular cancer therapeutics 2002;1(8):565-73.
2002: Haiyong Han; David J Bearss; L Walden Browne; Robert Calaluce; Raymond B Nagle; Daniel Von Hoff
Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray.
Cancer research 2002;62(10):2890-6.
2001: W Duan; Anupama Rangan; Hariprasad Vankayalapati; Mu-Yong Kim; Q Zeng; Daekyu Sun; Haiyong Han; OY Fedoroff; David Nishioka; S Y Rha; Elzbieta Izbicka; Daniel Von Hoff; Laurence H Hurley
Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects.
Molecular cancer therapeutics 2001;1(2):103-20.
2001: Haiyong Han; D R Langley; Anupama Rangan; Laurence H Hurley
Selective interactions of cationic porphyrins with G-quadruplex structures.
Journal of the American Chemical Society 2001;123(37):8902-13.
2000: Haiyong Han; R J Bennett; Laurence H Hurley
Inhibition of unwinding of G-quadruplex structures by Sgs1 helicase in the presence of N,N'-bis[2-(1-piperidino)ethyl]-3,4,9,10-perylenetetracarboxylic diimide, a G-quadruplex-interactive ligand.
Biochemistry 2000;39(31):9311-6.
2000: Haiyong Han; Laurence H Hurley
G-quadruplex DNA: a potential target for anti-cancer drug design.
Trends in pharmacological sciences 2000;21(4):136-42.
2000: Laurence H Hurley; RT Wheelhouse; Daekyu Sun; Sean M Kerwin; Miguel Salazar; OY Fedoroff; F X Han; Haiyong Han; Elzbieta Izbicka; Daniel Von Hoff
G-quadruplexes as targets for drug design.
Pharmacology & therapeutics 2000;85(3):141-58.
1999: Haiyong Han; C L Cliff; Laurence H Hurley
Accelerated assembly of G-quadruplex structures by a small molecule.
Biochemistry 1999;38(22):6981-6.
1999: Haiyong Han; Laurence H Hurley; Miguel Salazar
A DNA polymerase stop assay for G-quadruplex-interactive compounds.
Nucleic acids research 1999;27(2):537-42.
1998: OY Fedoroff; Miguel Salazar; Haiyong Han; Violetta Chemeris; Sean M Kerwin; Laurence H Hurley
NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA.
Biochemistry 1998;37(36):12367-74.